Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: A test-negative study

Vaccine

Volumn 33, Issue 2, 2015, Pages 367-373

  Lytras, Theodore ^a,b,c   Kossyvakis, Athanasios ^d   Melidou, Angeliki ^e   Exindari, Maria ^e   Gioula, Georgia ^e   Pogka, Vasiliki ^e   Malisiovas, Nikolaos ^e   Mentis, Andreas ^d  

^a Hellenic Centre for Disease Control and Prevention   (Greece)

^b CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d HELLENIC PASTEUR INSTITUTE   (Greece)

^e ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Epidemiology; Influenza; Influenza like illness ILI; Molecular methods; Surveillance; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; DRUG EFFICACY; FEMALE; GREECE; HOSPITAL PHYSICIAN; HUMAN; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VACCINATION; INFLUENZA VIRUS A H3N2; LABORATORY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASON; AGED; CASE CONTROL STUDY; EPIDEMIOLOGY; HEALTH SURVEY; IMMUNOLOGY; INFANT; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA, HUMAN; MIDDLE AGED; PHYLOGENY; PRESCHOOL CHILD; SENTINEL SURVEILLANCE; STATISTICAL MODEL; TIME; VACCINATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GREECE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; MIDDLE AGED; PHYLOGENY; POPULATION SURVEILLANCE; SEASONS; SENTINEL SURVEILLANCE; TIME FACTORS; VACCINATION; YOUNG ADULT;

EID: 84922377431     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.11.005     Document Type: Article

References (32)

1. Osterholm M.T., Kelley N.S., Sommer A., Belongia E.A. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12:36-44.
2. Ohmit S.E., Thompson M.G., Petrie J.G., Thaker S.N., Jackson M.L., Belongia E.A., et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014, 58:319-327.
3. Cheng A.C., Holmes M., Irving L.B., Brown S.G.A., Waterer G.W., Korman T.M., et al. Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational study. PLoS One 2013, 8:e68760.
4. Kissling E., Valenciano M., Buchholz U., Larrauri A., Cohen J.M., Nunes B., et al. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. Euro Surveill 2014, 19. pii=20701.
5. Skowronski D., Chambers C., Sabaiduc S., De Serres G., Dickinson J., Winter A., et al. Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada's sentinel surveillance network January 2014. Euro Surveill 2014, 19. pii=20690.
6. Pebody R.G., Andrews N., McMenamin J., Durnall H., Ellis J., Thompson C.I., et al. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Euro Surveill 2013, 18. pii=20389.
7. Kelly H., Carville K., Grant K., Jacoby P., Tran T., Barr I. Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS One 2009, 4:e5079.
8. Jackson M.L., Nelson J.C. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013, 31:2165-2168.
9. Mereckiene J., Cotter S., D'Ancona F., Giambi C., Nicoll A., Levy-Bruhl D., et al. Differences in national influenza vaccination policies across the European Union Norway and Iceland 2008-2009. Euro Surveill 2010, 15. pii=19700.
10. Annual report of influenza epidemiologic surveillance 2012-2013 2013, Hellenic Centre for Disease Control Prevention, HCDCP, Athens.
11. Athanasiou M., Baka A., Andreopoulou A., Spala G., Karageorgou K., Kostopoulos L., et al. Influenza surveillance during the post-pandemic influenza 2010/11 season in Greece, 04 October 2010 to 22 May 2011. Euro Surveill 2011, 16. pii=20004.
12. Mpouloutza P. Greece first in influenza deaths in proportion to its population (in Greek) 2014, Kathimerini, Athens, http://www.kathimerini.gr/759615.
13. Rodrigues L., Kirkwood B.R. Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls. Int J Epidemiol 1990, 19:205-213.
14. Foppa I.M., Haber M., Ferdinands J.M., Shay D.K. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013, 31:3104-3109.
15. Orenstein E.W., De Serres G., Haber M.J., Shay D.K., Bridges C.B., Gargiullo P., et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007, 36:623-631.
16. R: A language and environment for statistical computing 2013, R Core Team, R Foundation for Statistical Computing, Vienna, Austria.
17. Melidou A., Gioula G., Exindari M., Chatzidimitriou D., Diza E., Malisiovas N. Molecular and phylogenetic analysis of the haemagglutinin gene of pandemic influenza H1N1 2009 viruses associated with severe and fatal infections. Virus Res 2010, 151:192-199.
18. Wilson I.A., Cox N.J. Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 1990, 8:737-771.
19. Belongia E.A., Kieke B.A., Donahue J.G., Coleman L.A., Irving S.A., Meece J.K., et al. Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. Vaccine 2011, 29:6558-6563.
20. Sullivan S.G., Kelly H. Late season interim estimates of influenza vaccine effectiveness reliably predict end of season estimates in Victoria Australia, 2007 to 2012. Euro Surveill 2013, 18. pii=20605.
21. Castilla J., Martínez-Baz I., Navascués A., Fernandez-Alonso M., Reina G., Guevara M., et al. Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre Spain: 2013/14 mid-season analysis. Euro Surveill 2014, 19. pii=20700.
22. Seasonal influenza 2013-2014 in the EU/EEA countries 2014, European Centre for Disease Prevention and Control, ECDC, Stockholm.
23. Influenza virus characterisation, summary Europe April 2014 2014, European Centre for Disease Prevention and Control, ECDC, Stockholm.
24. Skowronski D.M., Janjua N.Z., De Serres G., Sabaiduc S., Eshaghi A., Dickinson J.A., et al. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One 2014, 9:e92153.
25. Jefferson T., Di Pietrantonj C., Al-Ansary L.A., Ferroni E., Thorning S., Thomas R.E. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010, (2):CD004876.
26. Beyer W.E.P., McElhaney J., Smith D.J., Monto A.S., Nguyen-Van-Tam J.S., Osterhaus A.D.M.E. Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine 2013, 31:6030-6033.
27. Darvishian M., Gefenaite G., Turner R.M., Pechlivanoglou P., Van der Hoek W., Van den Heuvel E.R., et al. After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly. J Clin Epidemiol 2014, 67:734-744.
28. Kelly H., Peck H.A., Laurie K.L., Wu P., Nishiura H., Cowling B.J. The age-specific cumulative incidence of infection with pandemic influenza H1N1 2009 was similar in various countries prior to vaccination. PLoS ONE 2011, 6:e21828.
29. Verma N., Dimitrova M., Carter D.M., Crevar C.J., Ross T.M., Golding H., et al. Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children. J Virol 2012, 86:5515-5522.
30. Suzuki M., Yoshimine H., Harada Y., Tsuchiya N., Shimada I., Ariyoshi K., et al. Estimating the influenza vaccine effectiveness against medically attended influenza in clinical settings: a hospital-based case-control study with a rapid diagnostic test in Japan. PLoS One 2013, 8:e52103.
31. Jacoby P., Kelly H. Is it necessary to adjust for calendar time in a test negative design?: Responding to: Jackson ML, Nelson JC. The test negative design for estimating influenza vaccine effectiveness. Vaccine 2014, 32:2942.
32. Fry A.M., Kim I.K., Reed C., Thompson M., Chaves S.S., Finelli L., et al. Modeling the effect of different vaccine effectiveness estimates on the number of vaccine-prevented influenza-associated hospitalizations in older adults. Clin Infect Dis 2014, 59:406-409.